Products and investments
Products, customers and applications |
|||
Indications and sectors |
|
Applications |
Example products |
---|---|---|---|
Fungicides |
|
Protecting crops from harmful fungal infections; improving plant health |
Boscalid, metiram, dimethomorph, Initium®, metrafenone, F 500®, Xemium®, AgCelence® (umbrella brand) |
Herbicides |
|
Reducing competition from weeds for water and nutrients |
Kixor®, dicamba, pendimethalin, imazamox, topramezone, Clearfield® herbicide tolerance system, dimethenamid-P |
Insecticides |
|
Combating insect pests in agriculture and beyond, such as in the fields of public health, professional pest control and landscape maintenance |
Fipronil, alpha-cypermethrin, chlorfenapyr, teflubenzuron, Nealta®, Termidor® to guard against termite infestation, Interceptor® mosquito nets to protect against malaria |
Functional Crop Care |
|
Products for plant health and increased yield potential that go beyond traditional crop protection, such as biological crop protection, seed treatments, polymers and colorants |
Vizura®, Limus®, Systiva®, Vault® HP, Nodulator® PRO, Flo Rite®, Integral®, Serifel® |
Investments
In 2016, we invested €205 million in property, plant and equipment. Most of this investment amount is attributable to the expansion of dicamba production capacity in Beaumont, Texas. We also increased capacities for the fungicide Xemium® and enlarged a formulation plant for fungicides in Tarragona, Spain. Furthermore, we are continuing to invest in innovative solutions that go beyond classic crop protection. One example from the area of Functional Crop Care is our new research and development center for biological crop protection and seed solutions in Limburgerhof, Germany, which combines expertise in chemical and biological solutions. In order to continue meeting the ongoing high demand for our innovative products in the future, we will invest around €840 million in developing and expanding our infrastructure and in our production and formulation capacities for active ingredients between 2017 and 2021.